RxDoctor Payments Data

Trent Nourse, PA

Physician Assistant · Fairborn, OHNPI 1821091455

Payments from drug & device makers

$1,707in general payments, 2019–2025

Across 130 payments — averaging $13.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$727
  • Novo Nordisk$189
  • Pfizer$164
  • Dexcom, Inc.$91
  • Amgen$74
  • Novartis$69
  • plus $394 from 12 others

What the payments were for

  • Food & beverage$1,707100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,707 in reported general payments places this provider in the 85th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$56,018
Medicare patients
183
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide96$106,120
JardianceEmpagliflozin73$100,596
MounjaroTirzepatide69$79,898
TrulicityDulaglutide47$51,834
JanuviaSitagliptin Phosphate49$51,532
FarxigaDapagliflozin Propanediol44$51,474
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$42,734
XareltoRivaroxaban21$25,042
Breo ElliptaFluticasone/Vilanterol32$16,303
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$13,110
Tresiba Flextouch U-100Insulin Degludec20$11,467
Spiriva RespimatTiotropium Bromide12$8,389
DuleraMometasone/Formoterol15$7,143
Repatha SureclickEvolocumab11$6,018
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$5,897

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$27$131,732116 claims
Boehringer IngelheimJardiance, Spiriva Respimat$41$108,98585 claims
Novo NordiskOzempic$189$106,12096 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$48$72,14687 claims
Johnson & JohnsonXarelto$25$25,04221 claims
AbbVieSynthroid$727$1,58537 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Fairborn

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →